chr14-23386436-A-G

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_002471.4(MYH6):ā€‹c.4838T>Cā€‹(p.Val1613Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,612,612 control chromosomes in the GnomAD database, including 600 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.037 ( 315 hom., cov: 32)
Exomes š‘“: 0.0076 ( 285 hom. )

Consequence

MYH6
NM_002471.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 8.00
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), MYH6. . Gene score misZ 0.85843 (greater than the threshold 3.09). Trascript score misZ 4.1282 (greater than threshold 3.09). GenCC has associacion of gene with dilated cardiomyopathy, hypertrophic cardiomyopathy, Keppen-Lubinsky syndrome, atrial septal defect 3, familial isolated dilated cardiomyopathy, hypertrophic cardiomyopathy 14.
BP4
Computational evidence support a benign effect (MetaRNN=0.0017161071).
BP6
Variant 14-23386436-A-G is Benign according to our data. Variant chr14-23386436-A-G is described in ClinVar as [Benign]. Clinvar id is 44522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-23386436-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH6NM_002471.4 linkuse as main transcriptc.4838T>C p.Val1613Ala missense_variant 33/39 ENST00000405093.9 NP_002462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH6ENST00000405093.9 linkuse as main transcriptc.4838T>C p.Val1613Ala missense_variant 33/395 NM_002471.4 ENSP00000386041 P1

Frequencies

GnomAD3 genomes
AF:
0.0371
AC:
5638
AN:
151894
Hom.:
315
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0144
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.0170
Gnomad SAS
AF:
0.00728
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00491
Gnomad OTH
AF:
0.0255
GnomAD3 exomes
AF:
0.0111
AC:
2775
AN:
250324
Hom.:
132
AF XY:
0.00941
AC XY:
1275
AN XY:
135450
show subpopulations
Gnomad AFR exome
AF:
0.105
Gnomad AMR exome
AF:
0.00814
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.0138
Gnomad SAS exome
AF:
0.00569
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00320
Gnomad OTH exome
AF:
0.00930
GnomAD4 exome
AF:
0.00759
AC:
11085
AN:
1460600
Hom.:
285
Cov.:
72
AF XY:
0.00701
AC XY:
5095
AN XY:
726582
show subpopulations
Gnomad4 AFR exome
AF:
0.114
Gnomad4 AMR exome
AF:
0.00968
Gnomad4 ASJ exome
AF:
0.00130
Gnomad4 EAS exome
AF:
0.0123
Gnomad4 SAS exome
AF:
0.00609
Gnomad4 FIN exome
AF:
0.000300
Gnomad4 NFE exome
AF:
0.00454
Gnomad4 OTH exome
AF:
0.0123
GnomAD4 genome
AF:
0.0372
AC:
5655
AN:
152012
Hom.:
315
Cov.:
32
AF XY:
0.0356
AC XY:
2648
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.119
Gnomad4 AMR
AF:
0.0144
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.0171
Gnomad4 SAS
AF:
0.00728
Gnomad4 FIN
AF:
0.0000945
Gnomad4 NFE
AF:
0.00491
Gnomad4 OTH
AF:
0.0252
Alfa
AF:
0.0113
Hom.:
19
Bravo
AF:
0.0429
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.0420
AC:
185
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.0149
AC:
1806

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJun 15, 2016- -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineDec 27, 2011- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 24, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hypertrophic cardiomyopathy 14 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 08, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
19
DANN
Benign
0.87
DEOGEN2
Benign
0.33
T;T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.47
T;.
MetaRNN
Benign
0.0017
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.3
N;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
2.6
N;N
REVEL
Benign
0.24
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.20
MPC
0.30
ClinPred
0.0080
T
GERP RS
4.5
Varity_R
0.054
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61742476; hg19: chr14-23855645; COSMIC: COSV62450812; COSMIC: COSV62450812; API